Clinical Trials Related to Squamous Cell Carcinoma of the Anal Canal

Related studies linked through entity extraction aliases.

Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer

Status: NOT_YET_RECRUITING
Phase: N/A

An Early Access Program Guideline to Provide Access to Retifanlimab (INCMGA00012) Together With Carboplatin and Paclitaxel for Squamous Carcinoma of the Anal Canal (SCAC)

Status: AVAILABLE
Phase: N/A

Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS)

Status: RECRUITING
Phase: PHASE2

Tumor Recurrence After Abdominal-perineal Amputation in Squamous Cell Carcinoma of the Anus

Status: COMPLETED
Phase: N/A

Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

Status: COMPLETED
Phase: PHASE3